Shows
ReachMD CMEPractical Tips for GLP-1 RA Therapy SuccessCME credits: 0.50
Valid until: 30-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/practical-tips-for-glp-1-ra-therapy-success/35830/
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CI...
2025-05-3000 minReachMD CMEBeyond the Scale: How to Tackle Obesity’s ComorbiditiesCME credits: 0.50
Valid until: 30-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-scale-how-to-tackle-obesitys-comorbidities/35829/
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www...
2025-05-3000 minReachMD CMETreating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery Treating Obesity: Lifelong Strategies fFrom Lifestyle to Pharmacotherapy and SurgeryCME credits: 0.50
Valid until: 30-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/treating-obesity-lifelong-strategies-from-lifestyle-to-pharmacotherapy-and-surgery-treating-obesity-lifelong-strategies-ffrom-lifestyle-to-pharmacotherapy-and-surgery/35828/
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www...
2025-05-3000 minReachMD CMEObesity: Unmasking the Chronic Disease Beneath the WeightCME credits: 0.50
Valid until: 30-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/obesity-unmasking-the-chronic-disease-beneath-the-weight/35826/
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www...
2025-05-3000 minReachMD CMEObesity and Comorbidities: Strategies for Effective Patient ManagementCME credits: 0.50
Valid until: 30-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/obesity-and-comorbidities-strategies-for-effective-patient-management/35827/
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care. This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www...
2025-05-3000 minReachMD CMEInsights from Experts: Preventing and Managing CMV Post-Solid Organ TransplantCME credits: 0.75
Valid until: 08-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/insights-from-experts-preventing-and-managing-cmv-post-solid-organ-transplant/32966/
Join experts, Fernanda P. Silveira, MD, MS, FIDSA, FAST and Jennifer Saullo, MD, PharmD, FIDSA, as they delve into the complexities of cytomegalovirus (CMV) prevention and treatment following solid organ transplantation (SOT). Presentations will feature detailed case discussions with a focus on managing resistant and refractory disease, addressing treatment-related toxicities, and optimizing therapeutic strategies. This program is an essential primer on the scientific challenges and solutions in this critical area of transplant medicine. =
2025-05-0900 minReachMD CMENew Frontiers in the Treatment of DMD Across the Age SpectrumCME credits: 1.00
Valid until: 09-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/new-frontiers-in-the-treatment-of-dmd-across-the-age-spectrum/32740/
Explore the latest treatment options, age-specific management strategies, and clinical trial data for patients with Duchenne muscular dystrophy (DMD). Through expert-led discussions and real-world patient cases, you’ll gain practical insights to help you confidently navigate today’s ever-evolving treatment landscape and deliver personalized, informed care.=
2025-05-0900 minReachMD CMEAdvancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIsCME credits: 1.00
Valid until: 09-05-2026
Claim your CME credit at https://reachmd.com/programs/cme/advancing-care-in-non-clear-cell-rcc-optimizing-ici-and-tkis/29872/
Stay at the forefront of nccRCC care by exploring the latest advances in treatment strategies. Gain key insights into optimizing patient selection, enhancing diagnostic accuracy, and managing adverse events to improve patient outcomes. This comprehensive activity delves into emerging data, the rationale for ICI/TKI combination therapy, the latest clinical trial findings, and best practices for treatment sequencing. Take action today to refine your approach and deliver the best possible care for your patients.=
2025-05-0900 minReachMD CMETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn TherapeuticsCME credits: 0.75
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/treatment-advances-in-generalized-myasthenia-gravis-a-pathophysiology-driven-framework-leveraging-fcrn-therapeutics/29537/
Traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial for many patients in the short term but often come with unacceptable side effects. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) has created a groundbreaking paradigm shift in our approach to both the short- and longer-term management of affected patients. Join Drs. Vera Bril and Neelam Goyal as they take a deep dive into this topic and discuss how FcRn inhibitors are changing the therapeutic...
2025-04-3000 minReachMD CMEMultidisciplinary Team Collaboration in the New Era of Hemophilia TreatmentCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/multidisciplinary-team-collaboration-in-the-new-era-of-hemophilia-treatment/35554/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEEvaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor MimeticsCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/evaluating-novel-factor-replacement-strategies-extended-and-ultra-half-life-factors-and-factor-mimetics/35548/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEEvaluating Emerging Treatment Options: Rebalancing TherapiesCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/evaluating-emerging-treatment-options-rebalancing-therapies/35549/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEThe Promise and Future of Gene TherapyCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/the-promise-and-future-of-gene-therapy/35550/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEConsidering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?CME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/considering-the-promise-of-new-and-emerging-treatments-for-hemophilia-the-need-for-iti/35551/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEConsidering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic RisksCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/considering-the-promise-of-new-and-emerging-treatments-for-hemophilia-managing-thrombotic-risks/35552/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEIntegrating New Therapies Into HealthcareCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/integrating-new-therapies-into-healthcare/35553/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEMoving Forward–What Is on the Horizon? Personalized Therapies for PatientsCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/moving-forwardwhat-is-on-the-horizon-personalized-therapies-for-patients/35555/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEThe Impact of Hemophilia Across Patients’ LivesCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/the-impact-of-hemophilia-across-patients-lives/35547/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEAn Overview of Current and Emerging Treatment Options for Hemophilia A & BCME credits: 1.25
Valid until: 30-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/an-overview-of-current-and-emerging-treatment-options-for-hemophilia-a-b/35546/
Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.
2025-04-3000 minReachMD CMEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral TherapeuticsCME credits: 0.50
Valid until: 25-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/enhancing-diagnosis-treatment-and-outcomes-in-paroxysmal-nocturnal-hemoglobinuria-with-novel-oral-therapeutics/32762/
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by hemolytic anemia and associated with thrombophilia and bone marrow failure. Early and accurate diagnosis and classification of PNH is essential to optimize outcomes. However, the diagnosis of PNH may be delayed or missed for months or even years in practice, and only 25% of newly diagnosed patients receive any PNH-specific treatment. Moreover, up to 20% of patients treated with C5 inhibitors continue to experience clinically significant extravascular hemolysis, leading to...
2025-04-2500 minReachMD CMEChairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug ConjugatesCME credits: 0.25
Valid until: 18-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-improving-hrher2-breast-cancer-outcomes-with-trop2-antibody-drug-conjugates/29875/
The recent approvals of therapies for hormone-receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer (MBC) have augmented the treatment armamentarium in this setting, giving clinicians more options for their patients. However, it may be challenging to select the optimal therapy for individual patients. Moreover, it is important to differentiate between the 2 available TROP2-directed antibody-drug conjugates (ADCs). This activity reviews challenges in treating HR+, HER2- MBC, the role of TROP2-directed ADCS, and how to...
2025-04-1800 minReachMD CMEFirst-line Chemotherapy Options in Metastatic PDACCME credits: 0.25
Valid until: 16-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/first-line-chemotherapy-options-in-metastatic-pdac/33135/
Pancreatic ductal adenocarcinoma, also known as PDAC, is a lethal disease that is usually diagnosed at an advanced stage with an extremely poor prognosis. Advancements in treatment regimens have improved survival rates, but early diagnosis is crucial for improving outcomes, and awareness of risk factors is vital for early diagnosis. Cytotoxic chemotherapy is the cornerstone of treatment for advanced or metastatic cases, although molecularly targeted therapies and immunotherapies may benefit select patients. Treatment selection depends on several factors, including...
2025-04-1600 minReachMD CMESecond-line Chemotherapy Options in Metastatic PDACCME credits: 0.25
Valid until: 16-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/second-line-chemotherapy-options-in-metastatic-pdac/33136/
Pancreatic ductal adenocarcinoma, also known as PDAC, is a lethal disease that is usually diagnosed at an advanced stage with an extremely poor prognosis. Advancements in treatment regimens have improved survival rates, but early diagnosis is crucial for improving outcomes, and awareness of risk factors is vital for early diagnosis. Cytotoxic chemotherapy is the cornerstone of treatment for advanced or metastatic cases, although molecularly targeted therapies and immunotherapies may benefit select patients. Treatment selection depends on several factors, including...
2025-04-1600 minReachMD CMEChairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular LymphomaCME credits: 0.25
Valid until: 15-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-core-concepts-for-community-based-practice-the-evolving-role-of-bispecific-antibody-therapy-in-relapsed-or-refractory-follicular-lymphoma/29191/
Dr. Tycel Phillips presents a summary and offers expert insights on relevant and timely advances in bispecific antibody therapy for the treatment of R/R FL. The activity reviews topics including differentiating approved bispecific antibodies, evidence- and guideline-based treatment planning, patient selection, practical considerations, and optimizing safety in the application of bispecific antibody therapy in R/R FL.=
2025-04-1500 minReachMD CMERevolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 ExpressionCME credits: 0.50
Valid until: 04-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/revolutionizing-diagnostic-precision-ai-driven-approaches-in-digital-pathology-and-her2-expression/29878/
With the availability of HER2-directed therapies, it’s important to accurately identify patients who would benefit from these therapies, particularly in breast cancer, where we now have a spectrum of HER2 positivity. Advances in technology have augmented the role of digital pathology (DP) and artificial intelligence (AI) in oncologic pathology. This activity demonstrates how DP/AI can be used for more accurate biomarker assessment and explores the impact this may have on patient outcomes.=
2025-04-0400 minReachMD CMEEstablishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural ProvidersCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/establishing-best-practices-for-collaborative-care-for-patients-with-ascvd-between-academic-and-rural-providers/29824/
This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.=
2025-04-0300 minReachMD CMETraditional MG Treatments: Balancing Benefits, Risks, and Side Effect ManagementCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/traditional-mg-treatments-balancing-benefits-risks-and-side-effect-management/32729/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMEOcular to Generalized MG: How and Why the Disease EvolvesCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/ocular-to-generalized-mg-how-and-why-the-disease-evolves/32733/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMEManaging Side Effects in FcRn Therapy: Best Practices for gMGCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/managing-side-effects-in-fcrn-therapy-best-practices-for-gmg/32732/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMENew Frontiers in MG: How FcRn Antagonists Are Changing MG TherapyCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/new-frontiers-in-mg-how-fcrn-antagonists-are-changing-mg-therapy/32731/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMEA Scientific Look at FcRn Antagonists: Mechanisms of Action ExplainedCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/a-scientific-look-at-fcrn-antagonists-mechanisms-of-action-explained/32730/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMEAutoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic RoleCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/autoantibodies-explained-anti-achr-anti-musk-and-their-diagnostic-role/32728/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMEDiagnostic Advances in gMG: Effective Tools and TechniquesCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-advances-in-gmg-effective-tools-and-techniques/32727/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMELiving with gMG: Navigating Personal, Professional, and Mental Health ChallengesCME credits: 1.00
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/living-with-gmg-navigating-personal-professional-and-mental-health-challenges/32726/
While traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial in the short term, new treatment options with fewer debilitating side effects and longer-term benefit are needed. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) have demonstrated in clinical trials and real-world experience that they address both of these needs. Join Drs. Vera Bril, Nicholas Silvestri, and Hans Katzberg as they discuss this exciting new therapeutic option and how it may change the treatment landscape...
2025-04-0200 minReachMD CMETreatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment SelectionCME credits: 0.75
Valid until: 02-04-2026
Claim your CME credit at https://reachmd.com/programs/cme/treatment-advances-in-generalized-myasthenia-gravis-clinical-and-laboratory-criteria-for-diagnosis-and-optimal-treatment-selection/29533/
The adult and pediatric diagnostic and treatment landscapes of generalized myasthenia gravis (gMG) are both similar and different. While current traditional therapies are often effective in the short term, selecting the most appropriate short- and longer-term treatment for each patient, whether adult or pediatric, brings with it unique individual challenges. These challenges include how best to utilize newer targeted agents in the treatment of gMG, such as the neonatal Fc receptor (FcRn) inhibitors. Join Drs. Vera Bril and Jonathan...
2025-04-0200 min
On the Frontlines of PsoriasisScreening for Axial Involvement in Psoriatic Patients
Host: Matthew S. Keller MD
Host: Monica Schwartzman, MD, MS
Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians help patients find the right medication? To discuss this topic together, Dr. Matthew Keller is joined by fellow ReachMD host, Dr. Monica Schwartzman, who is also a Rheumatologist.
2022-11-1800 min
DermConsultScreening for Axial Involvement in Psoriatic Patients
Host: Matthew S. Keller MD
Host: Monica Schwartzman, MD, MS
Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians help patients find the right medication? To discuss this topic together, Dr. Matthew Keller is joined by fellow ReachMD host, Dr. Monica Schwartzman, who is also a Rheumatologist.
2022-11-1800 minDermConsultHow Practicing Goodness Can Grow Your Business
Host: Matthew S. Keller MD
Guest: Michael Greenberg, MD
Are you looking to increase business at your dermatology practice? One simple solution is practicing goodness—in other words, being good and kind to your patients and their families. Joining Dr. Matthew Keller to explain why goodness is the best practice builder is fellow ReachMD Host Dr. Michael Greenberg.
2022-04-0500 min
UrologyAdvances in the Treatment of Neurogenic Detrusor Overactivity
Host: Jonathan C. Routh, MD, MPH, FAAP
Guest: Benjamin M. Whittam, MD, MS, FAAP, FACS
This Expert Exchange webcast is designed to enhance clinicians’ awareness of advances in the pharmacotherapeutic armamentarium for treating NDO in the pediatric population. View the Advances in the Treatment of Neurogenic Detrusor Overactivity Clinical Compendium here: https://cdn.reachmd.com/uploads/clinicalcompendium_ndo_v2_final.pdf
2021-12-2900 min
VacciNationCOVID-19 Vaccine Development & Rollout: How Did It Differ from Other Vaccination Efforts?Host: John J. Russell, MD The global pandemic incited the expedited development of COVID-19 vaccines. But how did that change the development process? ReachMD host and Family Medicine Physician, Dr. John Russell, tells us how the rollout of the COVID-19 vaccine differs from other vaccines and what it could mean for the medical field.
2021-10-2900 minVacciNationHow to Talk to Patients About the Delta Variant & COVID-19 VaccinesHost: Jennifer Caudle, DO Host: John J. Russell, MD “What makes the Delta variant different?” “I keep hearing about breakthrough infections, so are the COVID-19 vaccines effective?” These are just some of the questions patients now have amid the surge of the Delta variant, and many patients are turning to physicians for answers. That’s why ReachMD hosts and primary care physicians Drs. Jennifer Caudle and John Russell sit down to share their approach to answering these FAQs regarding the Delta variant, the COVID-19 vaccines, and more.
2021-09-3000 minVacciNationLooking Back to Look Forward: The History of mRNA VaccinesHost: John J. Russell, MD In order for us to better understand how mRNA vaccines were able to move beyond clinical trials amid the COVID-19 pandemic, we must first know how they were originally developed. That’s why ReachMD host and family medicine physician Dr. John Russell reviews the history of mRNA vaccines and how we can use them in the future.
2021-09-3000 minDermConsultA Talk on Topical Therapy: Dermatologists’ Experiences in Practice
Host: Michael Greenberg, MD
Host: Matthew S. Keller MD
Curious about the use of topical therapy to treat a variety of dermatological conditions like eczema and molluscum contagiosum? Here to share their experiences with topical therapy in clinical practice are ReachMD hosts Dr. Michael Greenberg and Dr. Matthew Keller.
2021-06-2400 minVacciNationFacing Fears About the COVID-19 Vaccines: How to Counsel Patients
Host: Jennifer Caudle, DO
Guest: John J. Russell, MD
As clinicians on the frontlines of the COVID-19 pandemic, we’re among the first to hear about our patients’ fears of the vaccines’ validity and safety. So how can we help address their concerns? ReachMD hosts Dr. Jennifer Caudle and Dr. John Russell sit down together to talk about how we can counsel patients who may be hesitant to receive the COVID-19 vaccine. Published March 16, 2021
2021-03-1700 min
Book ClubLyme: The First Epidemic of Climate Change
Guest: Mary Beth Pfeiffer
With cases being reported in every state and across 80 countries, Lyme disease has become one of the fastest growing vector-borne illnesses in the world. But have you ever wondered how this global health threat came to be? That’s what journalist Mary Beth Pfeiffer investigates in her book, Lyme: The First Epidemic of Climate Change, and with the ReachMD team.
2019-07-2400 minBook ClubThe Locum Life: A Physician’s Guide to Locum Tenens
Host: Matt Birnholz, MD
Guest: Andrew Wilner, MD, FACP, FAAN
To get a detailed picture of physicians’ personal experiences with locum tenens work, Dr. Matt Birnholz speaks with a very special guest: Dr. Andrew Wilner. Not only is he the author of The Locum Life: A Physician’s Guide to Locum Tenens, but he’s also one of ReachMD’s esteemed hosts!
2019-07-0300 min
Everyday Family MedicineHow Pelvic Floor Physical Therapy Can Help MS Patients
Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC
Frustrating multiple sclerosis (MS) symptoms like urinary frequency and incontinence can be detrimental to a patient’s quality of life, but there are resources available to help. To explore the benefits of pelvic floor physical therapy for MS, Dr. Jennifer Caudle sits down with two special guests: physical therapist Catherine Apicella from CORE 3 Physical Therapy and her patient—and ReachMD’s very own employee—Crystal Gouldey.
2019-03-1200 min
Beyond Skin Deep: Impacts of Psoriatic ArthritisA Multidisciplinary Approach to Care Coordination Challenges in Psoriatic ArthritisHost: Michael Greenberg, MD
Guest: Madelaine A. Feldman, MD, FACR
A multidisciplinary approach between dermatologists and rheumatologists is required for treating and caring for patients with psoriatic arthritis (PsA). So how should these two specialists work together to achieve the best outcome for their patients? What challenges do they each face, and how can they overcome them? Dr. Michael Greenberg, dermatologist from the Illinois Dermatology Institute, and Dr. Madelaine Feldman, Clinical Associate Professor of Medicine at Tulane University School of Medicine and practicing rheumatologist, come together to provide their perspectives from their careers on this...
2018-10-0400 min
Crohn’s & Colitis Foundation PerspectivesIBD: A Journey from Parent to Advocate Host: Jennifer Caudle, DO For many IBD patients and their parents, becoming involved with advocacy groups provides an excellent support system, especially since this can be a difficult disease to manage. But some also use these groups to make a difference not only locally, but also nationally. Sharing his personal-turned-professional journey with Dr. Jennifer Caudle is Frank Russomano, President and CEO of ReachMD, who is also joined by the President & CEO of the Crohn’s & Colitis Foundation, Michael Osso.
2018-09-2000 minCrohn’s & Colitis Foundation PerspectivesIBD: A Journey from Parent to Advocate Host: Jennifer Caudle, DO For many IBD patients and their parents, becoming involved with advocacy groups provides an excellent support system, especially since this can be a difficult disease to manage. But some also use these groups to make a difference not only locally, but also nationally. Sharing his personal-turned-professional journey with Dr. Jennifer Caudle is Frank Russomano, President and CEO of ReachMD, who is also joined by the President & CEO of the Crohn’s & Colitis Foundation, Michael Osso.
2018-09-2000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisUnrecognized Comorbidities of Psoriatic ArthritisGuest: Alexis Ogdie, MD, MSCE
Along with the management of psoriatic arthritis, many patients also struggle with multiple, underlying comorbidities, increasing the complexity of the disease. In a review of the associated comorbidities that can emerge from PsA, Dr. Alexis Ogdie brings another aspect to the forefront: the all-too-often underrecognized comorbidities and risk factors. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-08-2400 minBeyond Skin Deep: Impacts of Psoriatic ArthritisWhy Is Psoriatic Arthritis Often Misdiagnosed?Host: Matt Birnholz, MD
Guest: Alexis Ogdie, MD, MSCE
A healthy thirty-year-old and father of two was six to eight weeks into his disease activity when he finally found his way to Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania. Revisiting this case, Dr. Odgie takes us through her PsA patient’s journey to regain his health and happiness. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-08-2000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisNew Outcomes are Shaping the Psoriatic Arthritis Therapeutic LandscapeHost: Matt Birnholz, MD
Guest: Alexis Ogdie, MD, MSCE
New outcome measures provide the opportunity for a more patient-inclusive assessment of psoriatic arthritis. With the help of Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania, you can implement these in clinical practice and facilitate collaborative decision-making and improved outcomes with your patients. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
2018-08-2000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisBuilding Bridges: A Team-Based Approach to Psoriatic Arthritis CareHost: Matt Birnholz, MD
Guest: Alexis Ogdie, MD, MSCE
Due to the complexity of psoriatic arthritis, working with a team of physicians helps ensure all facets of this disease are being addressed, but how can you sustain a partnership? Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania, expresses the value of multidisciplinary teams in her practice to promote a patient-centered approach. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-08-2000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisCare Collaborations for Psoriatic Arthritis in the Dermatology SettingGuest: Adrienne Rencic, MD, PhD
Many psoriatic arthritis patients struggle in determining the proper physician they should seek for treatment and care management. Since dermatologists are usually consulted first due to skin manifestations, it’s crucial that they are able to recognize the symptoms of PsA and know when to refer the patient to another specialist. Dr. Adrienne Rencic, a dermatologist in Glen Mills, PA, emphasizes the power of communication to achieve good coordination of care. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced an...
2018-08-0100 minBeyond Skin Deep: Impacts of Psoriatic ArthritisA Look at the Multi-Organ Impact of PsAHost: Jennifer Caudle, DO
Guest: Marina Magrey, MD
As a multi-organ, systematic disease, psoriatic arthritis impacts a patient both physically and psychologically. By understanding the extent of impact on your patients’ quality of life, you are better equipped to reach the specified goals of treatment. To provide insight, Dr. Jennifer Caudle connects with Dr. Marina Magrey, Associate Professor at Case Western Reserve University. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals on...
2018-07-3000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisPsoriatic Arthritis: Moving Toward a Personalized ApproachHost: Jennifer Caudle, DO
Guest: Marina Magrey, MD
While there is no cure for psoriatic arthritis, there have been great strides in treatment options to minimize disease symptoms. Joining Dr. Jennifer Caudle to share her approach to treatment is Dr. Marina Magrey. Their conversation explores the current landscape of therapeutic targets and what might be on the horizon for psoriatic arthritis patients and their physicians. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health...
2018-07-3000 minBeyond Skin Deep: Impacts of Psoriatic ArthritisStories of Psoriatic Arthritis: A Mother's Journey to RecoveryHost: Matt Birnholz, MD
Guest: Robin K. Dore, MD
As a physician, perhaps the only thing more satisfying than successfully treating a patient’s psoriatic arthritis is hearing their sincere gratitude for the positive impact the prescribed therapy has had on their life, as Dr. Robin Dore experienced in this patient case featuring a young mother who was apprehensive to begin treatment. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only....
2018-07-1600 minBeyond Skin Deep: Impacts of Psoriatic ArthritisThe Emotional Toll of Psoriatic Skin LesionsGuest: Robin K. Dore, MD
The emotional burden of psoriatic arthritis stems from the development of skin lesions, which can be extremely damaging to a patient’s personal and professional relationships as Dr. Robin Dore explains. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-07-1600 minBeyond Skin Deep: Impacts of Psoriatic ArthritisStories of Psoriatic Arthritis: One Patient's Lifelong AfflictionHost: Matt Birnholz, MD
Guest: Robin Dore, MD
Like any other condition, early detection is critical in psoriatic arthritis, but as Dr. Robin Dore proved in this unique patient case of a woman who dealt with PsA for 40 years, it’s never too late to start therapy and improve a patient’s quality of life. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-07-1600 minBeyond Skin Deep: Impacts of Psoriatic ArthritisHow PASI Scores Redefine Psoriatic Arthritis Patient CareGuest: Robin K. Dore, MD
Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-07-1600 minBeyond Skin Deep: Impacts of Psoriatic ArthritisUnderstanding Treat-to-Target Strategy in the Management of PsAGuest: Elizabeth Volkmann, MD, MS
What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care...
2018-07-0200 minBeyond Skin Deep: Impacts of Psoriatic ArthritisMinimal Disease Activity as Alternate Target in PsAGuest: Elizabeth Volkmann, MD, MS
When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-07-0200 minBeyond Skin Deep: Impacts of Psoriatic ArthritisWhy Clinical Skills are Crucial to Early Psoriatic Arthritis DiagnosisGuest: Joseph Huffstutter, MD
Diagnosing psoriatic arthritis (PsA) requires a thorough and thoughtful exam, but how can you be sure you’re not missing any symptoms? Join Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, as he dives into the best ways to screen your PsA patients. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
2018-06-1800 minBeyond Skin Deep: Impacts of Psoriatic ArthritisThe Impact of Positive Communication with PsA PatientsGuest: Joseph Huffstutter, MD
When you understand things from your patient’s perspective, you can have more powerful conversations about psoriatic arthritis (PsA) control. And to help you get inside a patient’s head, Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, describes the techniques he uses to understand a patient’s needs in order to find the best treatment option for their lifestyle. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series...
2018-06-1800 minBeyond Skin Deep: Impacts of Psoriatic ArthritisCould You Be Missing Symptoms in Your PsA Patients?Guest: Joseph Huffstutter, MD
Even the best rheumatologists aren’t mind readers, and it’s difficult to know that a patient is suffering if they don’t tell you. That’s why Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, breaks down communication methods that will help you uncover psoriatic arthritis (PsA) symptoms that your patients may not be disclosing. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health c...
2018-06-1800 minBeyond Skin Deep: Impacts of Psoriatic ArthritisHow You Can Overcome the Biggest Challenge in PsA Care CoordinationGuest: Joseph Huffstutter, MD
Care coordination is key in ensuring that your psoriatic arthritis (PsA) patients maintain control of their disease, but it’s not always easy. To help you overcome this common challenge, Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, shares his perspective on how you can coordinate your PsA patients’ care with not only their healthcare team but also their family members. Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This...
2018-06-1800 minCrohn’s & Colitis Foundation PerspectivesA Message from the President & CEO of Crohn’s & Colitis Foundation Hear from Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, as he talks about the Crohn’s & Colitis Foundation Perspectives series on ReachMD.
2018-05-2300 minCrohn’s & Colitis Foundation PerspectivesA Message from the President & CEO of Crohn’s & Colitis Foundation Hear from Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, as he talks about the Crohn’s & Colitis Foundation Perspectives series on ReachMD.
2018-05-2300 minCrohn’s & Colitis Foundation PerspectivesIBD & Intimacy: Managing an Under-Recognized Issue Host: Robert Frankel, MD Guest: Neilanjan Nandi, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Robert Frankel talks with Dr. Neilanjan Nandi, Assistant Professor in the Division of Gastroenterology & Hepatology and Associate Director of the Gastroenterology Fellowship program at Drexel University College of Medicine. Dr. Nandi shares new insights on how to approach sexual and intimacy issues for IBD patients. Discussion points include quality of life measures, methods for maintaining healthy intimate relationships, respecting boundaries, and top health practitioner resources.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesThe Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective Host: Philip Stein, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Claire Griffin and Bill Johnson, patients and counselors at CCF's Camp Oasis. Claire and Bill discuss their respective involvements with the camp, why they made the decision to go, how they became their own personal advocates, and what Camp Oasis taught them about adjusting to their disease.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesIBD Expert Panel: When is the Right Time to Refer to GI? Host: Brian P. McDonough, MD, FAAFP Guest: John D. Betteridge, MD Guest: Philip Stein, MD Guest: Thomas Judge, M.D. From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough moderates an expert gastroenterology panel exploring some of the top issues in IBD management: the best time for primary care clinicians to refer patients to GI, challenges to making an early diagnosis, and differences between IBD and IBS. Panel participants include: Dr. John Betteridge, Gastroenterologist at Lancaster General Hospital and Regional Gi Medical Center in Lancaster, PA Dr. Tom Judge...
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesIBD & Intimacy: Managing an Under-Recognized Issue Host: Robert Frankel, MD Guest: Neilanjan Nandi, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Robert Frankel talks with Dr. Neilanjan Nandi, Assistant Professor in the Division of Gastroenterology & Hepatology and Associate Director of the Gastroenterology Fellowship program at Drexel University College of Medicine. Dr. Nandi shares new insights on how to approach sexual and intimacy issues for IBD patients. Discussion points include quality of life measures, methods for maintaining healthy intimate relationships, respecting boundaries, and top health practitioner resources.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesTravel for IBD Patients: How to Help Them Prepare Host: Adam Ehrlich, MD, MPH Guest: Adam Kaufman, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Adam C. Ehrlich talks with Dr. Adam Kaufman, Gastroenterologist at Main Line Gastroenterology Associates. Dr. Kaufman brings to the forefront the importance of preparing your IBD patient for travel. Discussion points include scheduling a pre-travel counsel visit, medication choices and proper storage procedures, vaccination considerations, blood clot prophylaxis, and travel insurance.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesThe Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective Host: Philip Stein, MD Guest: Neilanjan Nandi, MD Guest: Susan Peck, MSN, CRNP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Dr. Neilanjan Nandi and nurse practitioner Susan Peck about their respective experiences with The Crohn’s & Colitis Foundation's Camp Oasis. This camp gives children with IBD the opportunity to meet other kids with the same chronic illness, teaching them how to cope with their disease, manage their own medical needs, try new sports and activities, build confidence and independence, and most importantly, spend quality time just being a kid.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesThe Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective Host: Philip Stein, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Claire Griffin and Bill Johnson, patients and counselors at CCF's Camp Oasis. Claire and Bill discuss their respective involvements with the camp, why they made the decision to go, how they became their own personal advocates, and what Camp Oasis taught them about adjusting to their disease.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesIBD Expert Panel: When is the Right Time to Refer to GI? Host: Brian P. McDonough, MD, FAAFP Guest: John D. Betteridge, MD Guest: Philip Stein, MD Guest: Thomas Judge, M.D. From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough moderates an expert gastroenterology panel exploring some of the top issues in IBD management: the best time for primary care clinicians to refer patients to GI, challenges to making an early diagnosis, and differences between IBD and IBS. Panel participants include: Dr. John Betteridge, Gastroenterologist at Lancaster General Hospital and Regional Gi Medical Center in Lancaster, PA Dr. Tom Judge...
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesTravel for IBD Patients: How to Help Them Prepare Host: Adam Ehrlich, MD, MPH Guest: Adam Kaufman, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Adam C. Ehrlich talks with Dr. Adam Kaufman, Gastroenterologist at Main Line Gastroenterology Associates. Dr. Kaufman brings to the forefront the importance of preparing your IBD patient for travel. Discussion points include scheduling a pre-travel counsel visit, medication choices and proper storage procedures, vaccination considerations, blood clot prophylaxis, and travel insurance.
2018-04-1200 minCrohn’s & Colitis Foundation PerspectivesThe Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective Host: Philip Stein, MD Guest: Neilanjan Nandi, MD Guest: Susan Peck, MSN, CRNP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Dr. Neilanjan Nandi and nurse practitioner Susan Peck about their respective experiences with The Crohn’s & Colitis Foundation's Camp Oasis. This camp gives children with IBD the opportunity to meet other kids with the same chronic illness, teaching them how to cope with their disease, manage their own medical needs, try new sports and activities, build confidence and independence, and most importantly, spend quality time just being a kid.
2018-04-1200 min
Voices From American MedicineControversies in Drug Pricing: How Will Capitol Hill Respond?Host: Frank Russomano
Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps? Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to...
2016-02-2200 minEveryday Family MedicineProviding Nonjudgmental Care for LGBT Populations: How to Recognize Unconscious Bias
Host: Jennifer Caudle, DO
LGBT populations are at increased risk for specific health issues across the age spectrum, from depression, suicidality and eating disorders in childhood to substance abuse, sexually transmitted infections, and domestic violence issues in adulthood. Yet within the clinical arena, unconscious biases by healthcare providers can make patients uncertain or afraid to contribute sensitive information disclosing their sexual orientation, leading to missed guidance and care opportunities for higher risk problems. In this episode of Everyday Family Medicine, Dr. Jennifer Caudle welcomes Dr. Joshua Coren from Rowan University School of Osteopathic Medicine to discuss what has...
2016-01-1100 min
Lipid LuminationsDyslipidemia in Children and Adolescents
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Host Dr. Alan Brown welcomes Dr. Don Wilson, Endocrinologist at Cook Children's Health Care System, Fort Worth, Texas. Dr. Wilson will review dyslipidemia in children and adolescent patients. Key points of their discussion will cover the association between abnormal lipid levels in children and an increased lifetime risk of atherosclerotic CVD, as well as, the CVD risk factors present in children and how it tracks from childhood to adulthood. Supported by an Educational Grant from AstraZeneca. Supported by an Educational Grant from AstraZeneca. - See...
2015-07-2000 min
Clinician's RoundtableNew Horizons for ReachMD
Host: Matt Birnholz, MD
Change: it's in the air at ReachMD. The word is out that a platform shift will be taking place on October 18th, where ReachMD will move from XM satellite radio to iHeart internet radio. But what does this momentous occasion mean for the ReachMD listenership community? Join host Dr. Matt Birnholz in leading an "in-house" investigation as he interviews a member of the ReachMD executive team, Frank Russomano, CEO of ReachMD.
2013-10-0900 minClinician's RoundtableNew Horizons for ReachMD
Host: Matt Birnholz, MD
Change: it's in the air at ReachMD. The word is out that a platform shift will be taking place on October 18th, where ReachMD will move from XM satellite radio to iHeart internet radio. But what does this momentous occasion mean for the ReachMD listenership community? Join host Dr. Matt Birnholz in leading an "in-house" investigation as he interviews a member of the ReachMD executive team, Frank Russomano, CEO of ReachMD.
2013-10-0900 minVoices From American MedicineFrom Mississippi — The Varied Interests of a PhysicianGuest: R. Scott Anderson, MD
Host: Gary Epstein
It's not uncommon for physicians to have varied interests and passions in addition to their full-time practice. Dr. Russell Scott Anderson, a radiation oncologist in rural Mississippi, has been a diving medical officer in the military, written a novel, made a movie, and paints in his spare time. He discusses the physician's capacity for multiple pursuits, with host ReachMD CEO Gary Epstein. This week's guest was nominated by theMississippi State Medical Association — an advocate for its 4,600-plus members, their patients, and the public health. ...
2011-03-1500 min
Second Opinion LIVE!The Mütter Museum & Other Spine-Tingling Topics in Medicine
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
Guest: Anna Dhody, MFS
Hosts Drs. Matt Birnholz and Michael Greenberg get into the Halloween spirit, with an interview with Anna Dhody, curator of the often macabre, always educational, Mütter Museum of The College of Physicians of Philadelphia. Plus, they discucss the results of ReachMD's poll of healthcare professionals' opinions on healthcare reform legislation. And, we want to know what YOU think. Tell us your reaction to federal healthcare reform legislation. Vote and post your comments in the online version of the poll.
2010-10-2600 minSecond Opinion LIVE!Haiti Six Months Later: Assessing the Aftermath
Guest: Anthony Alessi, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
In this show, our hosts get an update from ReachMD host Dr. Anthony Alessi, from Haiti, six months after the earthquake. And, they question Dr. Andrew Wakefield, widely-known for his controversial and discredited research linking the MMR vaccine with autism. He has a new book about his experiences, Callous Disregard: Autism and Vaccines: The Truth Behind a Tragedy.
2010-07-0800 min
Conference CoverageAMA House of Delegates: In Conversation With the New AMA President
Host: John Armstrong, MD
Guest: Cecil Wilson, MD
It's been a big year for medicine, and the next promises to be just as significant. Although health system reform was sorely needed, there are still components that need to be addressed, not the least of which is the flawed Medicare payment formula. The new AMA president, Dr. Cecil Wilson, who is an internist from Winter Park, Florida, discusses how the AMA will work to improve the healthcare system and increase patient access to care in the coming year. Dr. Wilson also stresses the need for physicians to become...
2010-06-1800 minConference CoverageAMA House of Delegates: In Conversation With the New AMA President
Host: John Armstrong, MD
Guest: Cecil Wilson, MD
It's been a big year for medicine, and the next promises to be just as significant. Although health system reform was sorely needed, there are still components that need to be addressed, not the least of which is the flawed Medicare payment formula. The new AMA president, Dr. Cecil Wilson, who is an internist from Winter Park, Florida, discusses how the AMA will work to improve the healthcare system and increase patient access to care in the coming year. Dr. Wilson also stresses the need for physicians to become...
2010-06-1800 minSecond Opinion LIVE!Career Day: Assessing Your Life and Practice in the Clinical Profession
Guest: Neil Baum, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
Hosts Dr. Michael Greenberg and Dr. Matt Birnholz welcome this week's guests to talk about your practice and career: Dr. Neil Baum, author of Marketing Your Clinical Practice: Ethically, Effectively, Economically and Tim Rush, whose job-finder platform for healthcare professionals powers ReachMD's new Career Center. Plus, Believe it Not! an Indian yogi who hasn't had anything to eat or drink in 70 years.
2010-05-1300 minSecond Opinion LIVE!A Doctor's Right to Help Patients Die
Guest: Gerald Metz, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
Second Opinion Live speaks with the new medical director of the Final Exit Network, Dr. Gerald Metz. Dr. Metz has assumed this role as the former medical director has temporarily stepped aside pending the outcome of legal issues related to investigations and court issues in several states. Final Exit Network is an organization that provides "exit guides" to assist terminally ill people who want to "end their time on Earth." Other topics include discussion of recent court cases related to patenting human...
2010-04-1400 min
Partners in PracticeLooking Back at 100 PA Shows: Changes and New Directions
Guest: Michael Gerchufsky
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
In October 2007, the first program in the Clinicians Roundtable series focusing on the issues of physician assistants aired on ReachMD. This week's program celebrates our 100th show and introduces a new series, Partners in Practice, a new, expanded series addressing the concerns of both physician assistants and nurse practitioners. This week, host Lisa Dandrea Lenell looks back at two and a half years of PA topics and guests. She is joined by Michael Gerchufsky, editor of the journal ADVANCE for Physician Assistants to talk about changes in the...
2010-03-0800 minSecond Opinion LIVE!Update From Haiti: The Next Phase of the Medical Response
Guest: Anthony Alessi, MD
Host: Michael Greenberg, MD
Guest: Lewis Zirkle, MD
Guest: Daniel Fitzgerald, MD
Several weeks after the devastating earthquake in Haiti, we revisit the medical response with three physicians, all with different specialties and all with a deep connection to Haiti. Hosts Dr. Matt Birnholz and Dr. Michael Greenberg speak with Dr. Anthony Alessi, host of ReachMD's NeuroFrontiers and a practicing neurologist, who traveled to Haiti on a medical mission. We also also speak with Dr. Lewis G. Zirkle, Jr., an orthopedic surgeon who introduced the SIGN (Surgical Implant Generation Network) program...
2010-02-0400 minSecond Opinion LIVE!Is 'Alternative' Medicine Effective?
Guest: Josephine Briggs, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD
Joining our hosts this week is Dr. Josephine P. Brigggs, director of the National Center for Complementary and Alternative Medicine. Dr. Briggs brings her focus on translational research to the position. On the occasion of the 10th anniversary of the agency, Dr. Briggs discusses what has been learned and what can be expected in the future. Also on the program: a look back at the top medical stories of the year, a discussion of the latest ReachMD Poll, and the curious case...
2010-01-0700 minConference CoveragePRESIDENT OBAMA ADDRESSES AMERICA'S PHYSICIANS
Host: John Armstrong, MD
All this week on the radio at XM 160 and online at www.ReachMD.com ReachMD brings you coverage of President Barack Obama's unprecedented keynote address to the American Medical Association's House of Delegates at their 158th annual meeting. And don't miss the multimedia presentation of the President's speech from American Medical News. Audio courtesy of ReachMD.
2009-06-1200 minConference CoveragePRESIDENT OBAMA ADDRESSES AMERICA'S PHYSICIANS
Host: John Armstrong, MD
All this week on the radio at XM 160 and online at www.ReachMD.com ReachMD brings you coverage of President Barack Obama's unprecedented keynote address to the American Medical Association's House of Delegates at their 158th annual meeting. And don't miss the multimedia presentation of the President's speech from American Medical News. Audio courtesy of ReachMD.
2009-06-1200 minBook ClubWill Science Replace Religion?
Guest: Taner Edis, PhD
Host: Leslie P. Lundt, MD
Why is the US more religious than Western Europe? Why does stem-cell research stir up so much controversy? ReachMD Book Club host Dr. Leslie Lundt welcomes author Taner Edis, PhD to discuss his book, Science and Nonbelief.
2008-02-1900 minBook ClubScience and Nonbelief: a Discussion on Religion's Place in Scientific Communities
Guest: Taner Edis, PhD
Host: Leslie P. Lundt, MD
Richard Dawkins is famous for saying science supports religious nonbelief, but many good scientists, such as Francis Collins, are religious and strongly oppose Dawkins's position. Where do you stand on this question? Physics professor and author Taner Edis, PhD discusses his book, Science and Nonbelief with host Dr. Leslie Lundt on the ReachMD Book Club.
2008-02-1900 minBook ClubSex, Sleep, Eat, Drink, Dream: Part 2
Host: Leslie P. Lundt, MD
Guest: Jennifer Ackerman
Jennifer Ackerman reminds us that Don Quixote called hunger "la major salsa del mundo" the world’s best sauce. What have we learned about appetite, hunger and digestion in recent years? Join ReachMD Book Club host Dr. Leslie Lundt as she welcomes the author of Sex, Sleep, Eat, Drink, Dream.
2007-11-0600 minBook ClubSex, Sleep, Eat, Drink, Dream: Part 1
Guest: Jennifer Ackerman
Host: Leslie P. Lundt, MD
People magazine has said that Jennifer Ackerman is “blessed with a naturalist’s eye for detail and a poet’s soul’. Her book beautifully describes how the body is a system of finely tuned clocks. She weaves cutting edge science with poetic descriptions of the impact that circadian biology has on nearly every aspect of our lives. ReachMD Book Club host Dr. Leslie Lundt discusses “Sex, Sleep, Eat, Drink, Dream” with author Jennifer Ackerman.
2007-11-0600 min